Literature DB >> 28151796

Clinical and Prognostic Features of Patients With Esophageal Cancer and Multiple Primary Cancers: A Retrospective Single-institution Study.

Yoshifumi Baba1, Naoya Yoshida1, Koichi Kinoshita1, Masaaki Iwatsuki1, Yo-Ichi Yamashita1, Akira Chikamoto1, Masayuki Watanabe2, Hideo Baba1.   

Abstract

OBJECTIVE: To investigate the clinical and prognostic characteristics of patients with esophageal cancer and multiple primary cancers. SUMMARY BACKGROUND DATA: Patients with esophageal cancer frequently have multiple primary cancers, the presence of which may complicate physicians' decision-making because the clinical and prognostic features of such patients remain unknown.
METHODS: This retrospective single-institution study included 538 consecutive patients who had undergone resection of esophageal cancer. The Cox proportional hazard model was used to compute the hazard ratio (HR) for mortality.
RESULTS: At the time of surgery, 163 patients (30%) had multiple primary cancers (77, metachronous; 86, synchronous). Multiple primary cancers were significantly associated with alcohol use and tobacco smoking (Brinkman index). Patients with synchronous cancers had significantly shorter overall survival than those without multiple primary cancers (log-rank P = 0.032; univariate HR = 1.53, 95% confidence interval 1.02-2.17, P = 0.040; multivariate HR: 1.61; 95% confidence interval: 1.08-2.36; P = 0.020). Patients with metachronous cancers had similar prognoses to those without multiple primary cancers. The prognostic effect of synchronous cancers on overall survival was particularly prominent in patients with Stage I esophageal cancer (log-rank P = 0.0002).
CONCLUSIONS: Multiple primary cancers are associated with a history of tobacco and alcohol use, supporting the concept of field cancerization. Synchronous multiple primary cancers may be an independent predictor of poorer long-term survival in patients undergoing resection of esophageal cancers.

Entities:  

Mesh:

Year:  2018        PMID: 28151796     DOI: 10.1097/SLA.0000000000002118

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  15 in total

1.  Development and verification of a hypoxia- and immune-associated prognosis signature for esophageal squamous cell carcinoma.

Authors:  Lian Lian; Shi-Bing Teng; You-You Xia; Xiao-Ming Shen; Yan Zheng; Shu-Guang Han; Wen-Jie Wang; Xue-Fei Xu; Chong Zhou
Journal:  J Gastrointest Oncol       Date:  2022-04

2.  Multiple primary malignancies for squamous cell carcinoma and adenocarcinoma of the esophagus.

Authors:  Dongni Chen; Ningbo Fan; Junxian Mo; Weidong Wang; Ruiqi Wang; Youfang Chen; Jia Hu; Zhesheng Wen
Journal:  J Thorac Dis       Date:  2019-08       Impact factor: 2.895

3.  Germline BRCA2 Truncating Mutation in Familial Esophageal Squamous Cell Carcinoma: A Case Controlled Study in China.

Authors:  Zhong Liang; Weidong Hu; Shuping Li; Zhenhong Wei; Zijiang Zhu
Journal:  Med Sci Monit       Date:  2020-06-24

4.  Comprehensive analysis of a new immune-related prognostic signature for esophageal cancer and its correlation with infiltrating immune cells and target genes.

Authors:  Zhang Peng; Xin-Yuan Liu; Zeng Cheng; Wu Kai; Zhao Song
Journal:  Ann Transl Med       Date:  2021-10

5.  Survival analysis of patients with primary breast duct carcinoma and lung adenocarcinoma: a population-based study from SEER.

Authors:  Fengyuan Lv; Mingliang Cheng; Liang Jiang; Xiaoping Zhao
Journal:  Sci Rep       Date:  2021-07-20       Impact factor: 4.379

6.  Impact of examined lymph node count on long-term survival of T1-2N0M0 double primary NSCLC patients after surgery: a SEER study.

Authors:  Kan Jiang; Xiaohui Zhi; Yue Shen; Yuanyuan Ma; Xinyu Su; Liqing Zhou
Journal:  PeerJ       Date:  2020-02-26       Impact factor: 2.984

7.  Second Primary Malignancies in Patients with Colorectal Cancer: A Population-Based Analysis.

Authors:  Huixun Jia; Qingguo Li; Jing Yuan; Xiaodong Sun; Zhenyu Wu
Journal:  Oncologist       Date:  2020-01-14

8.  ECCDIA: an interactive web tool for the comprehensive analysis of clinical and survival data of esophageal cancer patients.

Authors:  Jingcheng Yang; Jun Shang; Qian Song; Zuyi Yang; Jianing Chen; Ying Yu; Leming Shi
Journal:  BMC Cancer       Date:  2020-10-12       Impact factor: 4.430

9.  Clinicopathological features and prognosis of patients with esophageal cancer as the second primary cancer: a large population-based analysis using the SEER program [2000-2015].

Authors:  Zhencong Chen; Ming Li; Ke Ma; Zhengyang Hu; Shuai Wang; Hongyu Chen; Yuansheng Zheng; Cheng Zhan; Zongwu Lin; Qun Wang
Journal:  Transl Cancer Res       Date:  2020-02       Impact factor: 1.241

10.  Simultaneous renal clear cell carcinoma and primary clear cell carcinoma of the liver: A case report.

Authors:  Hua Jiang; Shanchao Zhao; Ganhong Li
Journal:  Medicine (Baltimore)       Date:  2020-11-20       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.